US Stocks
/
Cartesian Therapeutics, Inc. Share Price

Cartesian Therapeutics, Inc. Share Price

NASDAQ: RNAC | Micro Cap
$7.94
+$0.09 (1.15%) Last updated on 18 Sep, 2026 | 22:39 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Cartesian Therapeutics, Inc. Stock Performance

Open
$7.79
Prev. Close
$7.85
Circuit Range
N/A
Day Range
$7.71 - $7.95
Year Range
$5.66 - $10.88
Volume
2,442
Average Traded
$7.83

Cartesian Therapeutics, Inc. Share Price Today

As of 18 September 2026, Cartesian Therapeutics, Inc.'s share price is $7.94. The stock opened at $7.79, compared to its previous close of $7.85. During today's trading session, Cartesian Therapeutics, Inc.'s share price traded between $7.71 and $7.95, with an average price of $7.83. Over the past 52 weeks, the stock has recorded a high of $10.88 and a low of $5.66. In terms of performance, Cartesian Therapeutics, Inc.'s share price has risen by 28.58% over the last six months and is down 22.39% on a year-on-year basis.

Cartesian Therapeutics, Inc. Share Price Chart

$7.71$7.95
L
Show Current Price
H

Cartesian Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$206.23M
PE Ratio (TTM)
-1.58
Dividend Yield
N/A
EPS (TTM)
$-5.02
Revenue (TTM)
$400000.00
Return On Equity (TTM)
103.22%
Profit Margin
-32575.50%
Debt to Equity
-0.12
Quarterly Earnings Growth YoY
N/A

About Cartesian Therapeutics, Inc.

Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company's lead product candidate is Descartes-08, an autologous mRNA CAR-T directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune diseases, generalized myasthenia gravis, and systemic lupus erythematosus, as well as rare pediatric disease designation for the treatment of juvenile dermatomyositis. It is also developing Descartes-15, an autologous anti-BCMA mRNA CAR-T to treat autoimmune diseases, such as relapsed/refractory multiple myeloma. The company is headquartered in Frederick, Maryland.

Cartesian Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$9.02
$7.94
-20.52%
Aug 2026
$7.86
$9.99
+28.74%
Jul 2026
$10.30
$7.76
-25.53%
Jun 2026
$7.43
$10.42
+38.56%
May 2026
$6.33
$7.52
+20.80%
Apr 2026
$6.38
$6.22
+0.81%
Mar 2026
$7.36
$6.17
-18.64%
Feb 2026
$6.96
$7.59
+10.16%
Jan 2026
$7.23
$6.89
-4.31%
Dec 2025
$7.30
$7.20
-4.26%
Nov 2025
$8.19
$7.52
-7.89%
Oct 2025
$10.10
$8.16
-20.20%

RNAC Share Price FAQs

What is Cartesian Therapeutics, Inc. share price today?

chevron-up
Cartesian Therapeutics, Inc. share price today is $7.94 as on September 18, 2026 at 10:39 pm IST.

What is the 52 week high and 52 week low of Cartesian Therapeutics, Inc. stock?

chevron-up
The 52 week high of Cartesian Therapeutics, Inc. stock is $10.88, while the 52 week low is $5.66 as of 18 Sep '26.

What is RNAC's market capitalisation today?

chevron-up
RNAC market capitalisation is $206.23M as of September 18, 2026, at 10:40 pm IST.

What is the 5 year returns of RNAC?

chevron-up
The 5 year returns of RNAC is -93.64% as on 18 Sep '26.

What is the high & low stock price of RNAC today?

chevron-up
RNAC stock price hit a high of $7.95 and low of $7.71 as of 18 Sep '26.

Can I buy RNAC shares in India?

chevron-up
Yes. You can buy RNAC in India by opening an international trading account.